Pingki-an, Arlechris M.

HRN: 10-86-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2026
CEFTRIAXONE 1G (VIAL)
05/20/2026
05/27/2026
IV
2g
Q 24H
Multiple Lacerated Wounds, Left Leg And Left Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: